OncoDaily Grand Rounds at ESMO 2026: Partners Unite for Sarcoma Research
HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC
Remembering Rachna Shroff: The Sunshine She Leaves Behind
FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC
Pat Garcia-Gonzalez at LeukO 2026: The CML Breakthrough That Still Hasn't Reached Everyone
Jay Bhattacharya: NIH FY2026 Shows Strong Investment in Research
Patrick Soon-Shiong: New Publication Highlights Durable Responses in Non-Muscle-Invasive Bladder Cancer
Sanam Loghavi: Aplastic Anemia vs Hypocellular MDS, Solving Dameshek’s Riddle
OncoDaily Breast is OncoDaily’s dedicated platform for breast cancer, covering the rapidly evolving landscape of breast oncology. It focuses on the full spectrum of breast malignancies, including hormone receptor-positive/HER2-negative, HER2-positive, triple-negative, and other molecular subtypes. Through OncoDaily Breast, readers can follow the latest clinical trial developments, ongoing research, FDA and EMA approvals, guideline updates, emerging therapies, advances in biomarkers and precision oncology, major conference findings, and interviews with leading experts in breast cancer.
